Pishvaian MJ, Lee MS, Ryoo B, et al. Updated safety and clinical activity results from a Phase Ib study of atezolizumab + bevacizumab in hepatocellular carcinoma (HCC). ESMO 2018, abstract LBA26.
Adjuvant everolimus na operatie voor niercelcarcinoom: EVEREST
jan 2024 | Uro-oncologie